Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from SS Innovations International ( (SSII) ).
On March 6, 2026, SS Innovations International completed a privately negotiated sale of 5,774,839 shares of common stock, raising approximately $18.6 million in gross proceeds, led by significant insider participation from its chairman, vice chairman and a director alongside existing and new institutional investors. The capital injection, which includes a placement-related commission and warrant issuance to a FINRA member firm, is set to bolster working capital and fund global expansion, particularly scaling operations in India and other established territories while supporting regulatory and commercial preparations for entry into the U.S. and European Union surgical robotics markets.
The most recent analyst rating on (SSII) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on SS Innovations International stock, see the SSII Stock Forecast page.
Spark’s Take on SSII Stock
According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.
The score is held down primarily by weak financial performance (ongoing losses and negative operating cash flow) and bearish technicals (below key moving averages with negative MACD). Offsetting these are notably positive corporate events and rapid revenue/installation growth, but valuation remains constrained by unprofitability and no dividend support.
To see Spark’s full report on SSII stock, click here.
More about SS Innovations International
SS Innovations International, Inc. is a surgical robotics company that develops innovative, cost-effective robotic systems aimed at making advanced surgery more affordable and accessible globally. Its flagship SSi Mantra multi-arm surgical robotic platform and SSi Mudra instruments support a wide range of procedures, including cardiac surgery, with the company focusing on expanding its footprint from its base in India into major international markets.
Average Trading Volume: 97,376
Technical Sentiment Signal: Sell
Current Market Cap: $859.7M
For an in-depth examination of SSII stock, go to TipRanks’ Overview page.